Aubrey Capital Management’s CareDx CDNA Stock Holding History

Aubrey Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-105,200	Closed	-$3.79M	–	31
2019 Q2	$3.79M	Buy	+105,200	New	+$3.37M	1.81%	25

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Aubrey Capital Management's CDNA Position: Q3 2019 in Review

Aubrey Capital Management sold out of CareDx (CDNA) in Q3 2019, closing a stake of 105,200 shares — an estimated $3.79M sold.

Aubrey Capital Management first reported a position in CDNA in Q2 2019 and held it in 1 quarter. The position peaked at $3.79M in Q2 2019. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

Aubrey Capital Management reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
Aubrey Capital Management sold 105,200 CareDx shares in Q3 2019, an estimated $3.79M.
Aubrey Capital Management first reported a position in CareDx in Q2 2019 and held it in 1 quarter.
Aubrey Capital Management's CareDx position peaked at $3.79M in Q2 2019.
174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Aubrey Capital Management's 13F filing for Q3 2019, filed 4 Nov 2019.